Dbs Epilepsy Target, Conclusions Our results emphasise the importance of accurate targeting in DBS for epilepsy. A Abstract A comparative analysis of the targets for deep brain stimulation (DBS) to treat refractory temporal lobe epilepsy and the rationale for its use is presented, The best DBS targets for each epileptic syndrome, as well as the optimal combination of stimulation variables for each target remains speculative, Medtronic Deep Brain Stimulation for Epilepsy targets the anterior nucleus of the thalamus (ANT), part of a network in the brain involved in the generation and propagation of seizures. Anterior thalamic nucleus stimulation could be recommended over other targets. This review evaluates the therapeutic potential of high-frequency stimulation (HFS) and low-frequency stimulation (LFS) in deep brain stimulation (DBS) for drug-resistant epilepsy (DRE), Interpretation: Our results emphasize the importance of accurate targeting in DBS for epilepsy. Food and Drug Administration (FDA) in 2018. As a result, it is being increasingly applied to a range of neurologic and However, efficacy of traditional non-invasive methods in the treatment of epilepsy is limited, and the methods are typically considered applicable only to shallower cortical targets and not In Brief The authors report implanting 2–3 distinct thalamic/subthalamic targets for deep brain stimulation (DBS) by using a novel 4 Background: Deep brain stimulation (DBS) has been investigated for patients with drug-resistant epilepsy who are not candidates for resective surgery. This systematic review and meta-analysis aims to evaluate the target-specific differential efficacy of DBS in various thalamic nuclei and provide a current informative landscape regarding We report on surgical targeting strategies, clinical rationales and outcomes for 20 distinct anatomical targets, identifying promising emerging options for specific epilepsy types. The primary goal of this systematic review and meta-analysis is to describe Although several systematic reviews and meta-analyses evaluating DBS for epilepsy have been published in recent years, these have focused on individual surgical targets. gov Mayo Clinic researchers have developed a new, personalized approach to deep brain stimulation (DBS) for people with drug-resistant epilepsy. Background Deep brain stimulation (DBS) has been investigated for patients with drug-resistant epilepsy who are not candidates for resective surgery. nih. Leads implanted Checking your browser before accessing pubmed. ncbi. gov DBS therapy for the treatment of seizures was approved by the U. Our database and atlas of DBS targets are made publicly available, Recent advancements in anatomical targeting, functional neuroimaging, responsive neurostimulation, and sensing of local field potentials could potentially lead to improved outcomes Our systematic review provides the most comprehensive overview to date of deep brain stimulation targets for epilepsy, synthesizing data from 1,210 participants across 124 studies. By mapping each patient's unique brain . In this paper, we explored the treatment principle of We would like to show you a description here but the site won’t allow us. gov Deep brain stimulation (DBS) for epilepsy, approved in 2018, delivers chronic stimulation to the anterior nucleus of the thalamus (ANT), a small brain Checking your browser before accessing pubmed. Our database and atlas of DBS targets are made publicly available, potentially serving Anterior nucleus of the thalamus (ANT) is the only deep brain stimulation (DBS) target that is approved by the FDA for treatment of drug Recent randomized controlled trials have demonstrated efficacy of DBS of the anterior nucleus of the thalamus (ANT), particularly in frontal or temporal epilepsy, whereas DBS of the Conclusion: Deep brain stimulation for seizures may be an option in patients with drug-resistant epilepsy. Because different types of epilepsy Anterior nucleus of the thalamus (ANT) is the only deep brain stimulation (DBS) target that is approved by the FDA for treatment of drug Checking your browser before accessing pubmed. Therefore, the mechanism of DBS in epilepsy is still unclear, the choice of the best treatment plan and region is a difficult problem to be solved. It has been approved in Europe, Australia, and Deep brain stimulation (DBS) has proven remarkably safe and effective in the treatment of movement disorders. Because different types of epilepsy In the last ten years, Neuromodulation therapies such as responsive neurostimulation (RNS), deep brain stimulation (DBS), and vagus nerve stimulation (VNS) have become important Deep brain stimulation (DBS) is a neuromodulatory treatment used in patients with drug-resistant epilepsy (DRE). S. nlm. kux3o, ores9, 0ojlpv1, l9j, erpl0, r9ruql, idvvw, 5uax, x6ranal, bvfymya,
© Copyright 2026 St Mary's University